CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.6 GBX | -1.37% |
|
0.00% | +50.00% |
| 05-24 | Cambridge Nutritional Sciences appoints James Copper as COO | AN |
| 05-24 | Cambridge Nutritional Sciences Names COO | MT |
| Sales 2024 * | 9M 11.42M 15.59M | Sales 2025 * | - | Capitalization | 8.57M 10.87M 14.84M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.27M -1.73M | Net income 2025 * | - | EV / Sales 2024 * | 0.49 x |
| Net cash position 2024 * | 4.2M 5.33M 7.28M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-7.2
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 day | -1.37% | ||
| Current month | -13.25% | ||
| 1 month | -12.20% | ||
| 3 months | +9.09% | ||
| 6 months | +45.45% | ||
| Current year | +50.00% |
1 week
3.51
3.70
1 month
3.514.45
Current year
2.304.45
1 year
1.664.45
3 years
1.6661.00
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-25 | 3.6 | -1.37% | 126,146 |
| 24-06-24 | 3.65 | 0.00% | 1,340,091 |
| 24-06-21 | 3.65 | +1.39% | 888,868 |
| 24-06-20 | 3.6 | 0.00% | 179,987 |
| 24-06-19 | 3.6 | 0.00% | 81,352 |
Delayed Quote London S.E., June 25, 2024 at 11:35 am
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
2024-08-04
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +50.00% | 10.86M | |
| -12.05% | 7.33B | |
| +0.66% | 5.35B | |
| +32.11% | 5.68B | |
| -18.56% | 3.71B | |
| +5.52% | 2.49B | |
| -64.99% | 2.35B | |
| -11.50% | 2.22B | |
| +28.84% | 2.23B | |
| -15.91% | 1.61B |
- Stock Market
- Equities
- ODX Stock
